AACR Stories
Researching Ways to Intercept Cancer at Its Earliest Stages: Research led by Christina Curtis, PhD, MSc, has found tumors are "born to be bad" with metastatic potential present from the start.
Learn More in AACR Stories
Researching Ways to Intercept Cancer at Its Earliest Stages: Research led by Christina Curtis, PhD, MSc, has found tumors are "born to be bad" with metastatic potential present from the start.
Learn More in AACR Stories
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreTuesday, June 27, 2023 – The Critical Role of Regulatory Science. This free virtual forum will explore how regulatory science is evolving to meet the growing complexity of cancer research.
Learn More and RegisterNearly 300,000 women in the United States are expected to be diagnosed with breast cancer this year. Read about prevention, screening, and treatment options.
Learn MoreResearching Ways to Intercept Cancer at Its Earliest Stages: Dr. Christina Curtis’ research suggests tumors are “born to be bad” with metastatic potential present from the start.
Learn More in AACR StoriesRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research (AACR) has a lasting impact.
Donate NowSession recordings are available to registered attendees through July 19. Access to the sessions is still available for purchase.
The AACR Cancer Progress Report 2022 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 54,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreAACR President Lisa M. Coussens, PhD, FAACR, discusses the research-driven advances against cancer and looks to the future of cancer science and medicine.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Moretherapeutics against cancer were approved by the FDA from August 1, 2021, to July 31, 2022
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2019
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now
